COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
Vikas Lifecare shares rises 4% as its R&D unit receives government recognition

Vikas Lifecare shares rises 4% as its R&D unit receives government recognition

Vikas Lifecare will be eligible for receiving funds for R&D purpose from various government departments and agencies, and enable it to invest in equipments with lower tax liability after DSIR recognition

Pawan Kumar Nahar
Pawan Kumar Nahar
  • Updated Jan 17, 2023 10:56 AM IST
Vikas Lifecare shares rises 4% as its R&D unit receives government recognitionVikas Lifecare's shares have plunged more than 30 per cent in the last one month, whereas the stock has surged 75 per cent since May 2021.

Vikas Lifecare's shares rallied 4 per cent during early trade on Tuesday after the company's in-house research & development (R&D) unit received recognition from the Government of India. The Department of Scientific and Industrial Research (DSIR), which is under the Ministry of Science and Technology, has provided the recognition, the company said in an exchange filing.

Advertisement

DSIR recognition set-up by the Government of India for benchmarking of industrial R&D acknowledges the company's in-house R&D activities, the filing said.

Vikas Lifecares' shares jumped 4 per cent to Rs 4.65 on Tuesday, before giving up gains to trade at Rs 4.58 at 10.30 am. The penny stock had settled at Rs 4.48 on Monday. The trading and distribution company commanded a marketcap of Rs 675 crore.

Vikas Lifecare's shares have plunged more than 30 per cent in the last one month, whereas the stock has surged 75 per cent since May 2021. The stock has lost 45 per cent of its value from its 52-week high of Rs 8.15 in January 2022.

DSIR recognition for the company's R&D unit makes it eligible for receiving funds for R&D purposes from various government departments and agencies, and enables it to invest further into necessary equipment with reduced or zero tax liability.

Advertisement

R&D equipment could be imported with 100 per cent custom duty exemption whereas domestic equipment purchases will attract reduced GST rate of 5 per cent only. The benefits will reduce the company's expenses and improve its operational performance and net profit.

In case a product arising out of the R&D unit is patented in India and one more from another country (the US, China, or EU), the product can be sold without any excise duty for a period of three years.

Vikas Lifecare is engaged in various business segments including polymer & rubber commodity, compounds and master-Batches. It also manufactures up-cycled compounds from industrial and post-consumer waste and scrap materials. It also provides a wide variety of base polymers and commodity raw material to ONGC.

Advertisement

Also read: Nykaa shares fall 5%, hit record low. HSBC finds valuations attractive

Also read: $3 billion fund manager Ajay Tyagi says delayed gratification key to wealth creation

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Published on: Jan 17, 2023 10:56 AM IST
Post a comment0